Vancouver, British Columbia--(Newsfile Corp. - December 4, 2024) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical device company commercializing IzoView, a CT (computed tomography) imaging system, announces that due to the suspension of mail service in Canada due to the nationwide strike of the Canadian Union of Postal Workers, that the notice of meeting, information circular, requests for financial statements and proxy form (the "Meeting Materials") for the Company's upcoming Annual General Meeting will not be mailed and have been posted and are accessible on the Company's SEDAR+ profile and on the Company's website at https://izocorp.com/investors/agm/.

Shareholders may access the meeting materials at the aforementioned websites and can contact the Company at This email address is being protected from spambots. You need JavaScript enabled to view it. to obtain their voting control numbers that will be available on or before December 9, 2024, to vote their shares online at https://vote.odysseytrust.com.

Registered and beneficial shareholders who have provided prior e-consent to either Izotropic's trust company, Odyssey Trust, or their brokerage house, depository company or other intermediary with which they hold their shares will receive their meeting materials, instructions on how to vote, and voting control number via email from the organization in which their shares are held to vote their shares online at https://vote.odysseytrust.com.

Copies of the Company's annual audited, and quarterly interim financial statements and management's discussion and analysis are accessible on the Company's Sedar+ profile and on the Company's website at https://izocorp.com/investors/financials/.

ON BEHALF OF THE BOARD

About Izotropic

More information about Izotropic Corporation can be found on its website at izocorp.com and by reviewing its profile on SEDAR at sedar.com.

Forward-Looking Statements

This document may contain statements that are "Forward-Looking Statements," which are based upon the current estimates, assumptions, projections, and expectations of the Company's management, business, and its knowledge of the relevant market and economic environment in which it operates. The Company has tried, where possible, to identify such information and statements by using words such as "anticipate," "believe," "envision," "estimate," "expect," "intend," "may," "plan," "predict," "project," "target," "potential," "will," "would," "could," "should," "continue," "contemplate" and other similar expressions and derivations thereof in connection with any discussion of future events, trends or prospects or future operating or financial performance, although not all forward-looking statements contain these identifying words.

These statements are not guarantees of performance and involve risks, including those related to capital requirements and uncertainties that are difficult to control or predict, and as such, they may cause future results of the Company's activity to differ significantly from the content and implications of such statements. Forward-Looking Statements are pertinent only as of the date on which they are made, and the Company undertakes no obligation to update or revise any Forward-Looking Statements to reflect new information or the occurrence of future events or circumstances unless otherwise required to do so by law. Neither the Company nor its shareholders, officers, and consultants shall be liable for any action and the results of any action taken by any person based on the information contained herein, including, without limitation, the purchase or sale of Company securities. Nothing in this document should be deemed to be medical or other advice of any kind. All images are for illustrative purposes only. IzoView has not yet been approved or cleared for sale.